Cadence Capital Management’s Chemed CHE Stock Holding History

Cadence Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,265	Closed	-$946K	–	426
2019 Q3	$946K	Buy	+2,265	New	+$925K	0.13%	272

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Cadence Capital Management's CHE Position: Q4 2019 in Review

Cadence Capital Management sold out of Chemed (CHE) in Q4 2019, closing a stake of 2,265 shares — an estimated $946K sold.

Cadence Capital Management first reported a position in CHE in Q3 2019 and held it in 1 quarter. The position peaked at $946K in Q3 2019. 415 funds tracked by Wall St. Rank hold CHE as of Q4 2019.

Cadence Capital Management reported no remaining Chemed position as of Q4 2019 after selling out during the quarter.
Cadence Capital Management sold 2,265 Chemed shares in Q4 2019, an estimated $946K.
Cadence Capital Management first reported a position in Chemed in Q3 2019 and held it in 1 quarter.
Cadence Capital Management's Chemed position peaked at $946K in Q3 2019.
415 funds tracked by Wall St. Rank held Chemed as of Q4 2019.

Based on Cadence Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.